Novartis

Pharma / Pharmaceuticals and Healthcare

Founded 1996 Switzerland NVS CH0012005267 ⭐1000 DCF 139.37 💰107.99

ℹ️ Info

🧾 Overview 📎 Core Facts 🔥 Video Insights ⭐ Ratings 🧑‍💼 Executives 💬 My Comments

💡 Analytics

🏢 Company Q&A 🛠️ Industry Q&A 🏁 Competitors 📈 Stock Swings ⚡ SWOT 🏛️ PEST 🌀 Porter's Five Forces ✨ Score Positive ⚠️ Risks 🧩 Segmentation

💸 Financials

💵 Income Statement ⚖️ Balance Sheet 🔄 Cash Flow

📊 Ratios

📐 Financial Ratios 🌱 Growth 📏 Enterprise Value 📌 Key Metrics 💵 Dividends

🔧 Tools

✅ Due Diligence

📚 Resources

📰 News 🔶 Clusters 🗂️ SEC Filings 🔢 Stock Split History 📢 Press Releases 👤 Insider Trades 👑 Owner Earnings 📅 Earnings Calendar 🌐 Web 📝 Reports

Enterprise Value

Pay attention and research significant changes from year to year values. [ ! ]

Fixed Column	Stock Price	Number Of Shares	Market Capitalization	Minus Cash And Cash Equivalents	Add Total Debt	Enterprise Value
2024-12	97.31	1999.5	194571.34	11459.0	31258.0	214370.34
2023-12	100.97	2076.79	209693.9	13393.0	26348.0	222648.9
2022-12	85.85	2181.18	187254.33	7517.0	27964.0	207701.33
2021-12	82.77	2242.6	185620.09	12407.0	31093.0	204306.09
2020-12	****	****	****	****	****	****
2019-12	****	****	****	****	****	****
2018-12	****	****	****	****	****	****
2017-12	****	****	****	****	****	****
2016-12	****	****	****	****	****	****
2015-12	****	****	****	****	****	****
2014-12	****	****	****	****	****	****

💼 Explore more enterprise value data for Novartis!

📘 Claim your free eBook: "The Checklist Value Investor — A Smarter Way to Pick Stocks"

What is special about us?

Newsletter

Imprint

Disclaimer

×
Disclaimer

InsightfulValue is an independent platform dedicated to value investing research. The information provided on this website is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice.
We are not financial advisors, investment consultants, or licensed consultants. Our analyses, insights, and criteria are based on principles learned from renowned value investors such as Benjamin Graham, Warren Buffett, and Charlie Munger, but they should not be considered personalized investment recommendations.
Investing in financial markets carries risks, and past performance is not indicative of future results. Users of this website should conduct their own due diligence and consult with a qualified professional before making any financial or investment decisions. InsightfulValue assumes no liability for any financial losses or decisions made based on the information provided on this site.
By using this website, you acknowledge and accept that all investments involve risk and that InsightfulValue does not guarantee any financial outcomes.

Legal

Due Diligence

This feature is only available for users with Insider or Visionary license. Please, signup or login.